The primary objective of the study was to assess bioequivalence between the new ibuprofen formulation and the standard 200mg sugar-coated tablets ... to moderate pain is 200 to 400mg with a ...
Bioequivalence between 200mg tablets of ibuprofen lysinate and a new 200mg soft gelatin capsule was demonstrated. In accordance with previous results, this study confirmed again the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results